Search Results

Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), proudly announces results of the 2024 Industry Standard Research (ISR) Phase I CRO Benchmarking Report.

Enzolytics, Inc. (OTC PINK:ENZC) (“enzolytics.com”) (the “Company”) announced today that the Company is entering into a worldwide exclusive licensing agreement for US Patent # 8067531-B2, “Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells,” applying Immunotherapy Treatment to the global fight against cancer.

Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.

BBK Worldwide, the patient experience, recruitment, and engagement leader, announces the hiring of Veronica Moore as Account Specialist.

Xeris Biopharma Holdings, Inc. announced that it has entered into an exclusive worldwide collaboration and license agreement with Beta Bionics, Inc. for the development and commercialization of a glucagon product utilizing Xeris’ XeriSol™ technology for use in Beta Bionics’ proprietary bi-hormonal pump and pump systems.

BBK Worldwide, the patient experience, recruitment, and engagement leader, announces the hiring of Nicole DeMarco as Media and Research Strategist.